EGFR and intrahepatic cholangiocarcinoma: For instance, it has been found that the m7G mutation significantly increases the expression of genes involved in the cell cycle and the epidermal growth factor receptor (EGFR) pathway in intrahepatic cholangiocarcinoma (ICC) [52].